5/A

FORM 5/A SUBMISSION

Company: BridgeBio Pharma, Inc.
Filed: February 14, 2020
Period of Report: December 31, 2019
Accession Number: 0000899243-20-004685

View Document ↗ View on SEC.gov ↗